| CI | confidence interval |
| CT | chemotherapy |
| DURVA | durvalumab |
| ICI | immune checkpoint inhibitors |
| HRT | hypofractionated radiotherapy |
| MDSCs | myeloid-derived suppressor cells |
| NCDB | National Cancer Database |
| NK | natural killer |
| NNT | number needed to treat |
| NOS | Newcastle-Ottawa Scale |
| NSCLC | non-small cell lung cancer |
| OS | overall survival |
| PEMBRO | pembrolizumab |
| PD-1 | programmed cell death |
| RR | risk ratio |
| RT | radiotherapy |
| SBRT | stereobody radiotherapy |
| SE | standard errors |
| SFRT | standard fractionated radiotherapy |
| TAMs | tumor-associated macrophages |
| Treg | regulatory T cells |